Next Article in Journal / Special Issue
Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or “Innate Hypersensitivity”?
Previous Article in Journal
Down’s Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(6), 1222; doi:10.3390/ijms18061222

The Value of In Vitro Tests to Diminish Drug Challenges

1
Research Laboratory-Allergy Unit, Biomedical Institute of Málaga-IBIMA, Regional University Hospital of Malaga-UMA, Málaga 29009, Spain
2
Allergy Service, IBIMA-Regional University Hospital of Malaga-UMA, Málaga 29009, Spain
3
Department of Organic Chemistry, University of Málaga, Biomedical Institute of Málaga-IBIMA, Málaga 29071, Spain
4
Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Málaga 29590, Spain
*
Author to whom correspondence should be addressed.
Academic Editor: Werner J. P. Pichler
Received: 4 May 2017 / Revised: 31 May 2017 / Accepted: 2 June 2017 / Published: 7 June 2017
(This article belongs to the Special Issue Drug Hypersensitivity)
View Full-Text   |   Download PDF [1493 KB, uploaded 9 June 2017]   |  

Abstract

Drug hypersensitivity reactions have multiple implications for patient safety and health system costs, thus it is important to perform an accurate diagnosis. The diagnostic procedure includes a detailed clinical history, often unreliable; followed by skin tests, sometimes with low sensitivity or unavailable; and drug provocation testing, which is not risk-free for the patient, especially in severe reactions. In vitro tests could help to identify correctly the responsible agent, thus improving the diagnosis of these reactions, helping the physician to find safe alternatives, and reducing the need to perform drug provocation testing. However, it is necessary to confirm the sensitivity, specificity, negative and positive predictive values for these in vitro tests to enable their implementation in clinical practice. In this review, we have analyzed these parameters from different studies that have used in vitro test for evaluating drug hypersensitivity reactions and estimated the added value of these tests to the in vivo diagnosis. View Full-Text
Keywords: drug; hypersensitivity; allergy; diagnosis; in vitro; IgE; T-cells; basophils; cytokines; immunoassays drug; hypersensitivity; allergy; diagnosis; in vitro; IgE; T-cells; basophils; cytokines; immunoassays
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Mayorga, C.; Doña, I.; Perez-Inestrosa, E.; Fernández, T.D.; Torres, M.J. The Value of In Vitro Tests to Diminish Drug Challenges. Int. J. Mol. Sci. 2017, 18, 1222.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top